Stock Movemnet

Alongside the financial results, MPS informed the exchanges that its board had approved the incorporation of a Wholly Owned Subsidiary (WOS) in Singapore

The approval makes the innovator molecule from Novo Nordisk the first and only GLP-1 receptor agonist approved in India for the treatment of the disease.

The rally came after the company released its Vision & FAQs document along with a founder's note by managing director Sanjay Sharma

Turtlemint Fintech share surged 13.40 per cent to hit a fresh peak of ₹154.3 per share on the NSE during the intra-day trade

The Navratna stock recovered nearly 17 per cent from its 52-week low of ₹421.45, touched earlier this year on March 23, 2026, on the NSE

The upward movement in the company's share price came after it announced that it had secured an order worth $52.83 million, or approximately ₹503 crore, from Hyundai Engineering & Construction Co

So far this year, shares of Insolation Energy have gained 29 per cent, outperforming the benchmark Nifty50, which has declined 8 per cent during the same period

The upward movement came after the company issued a clarification on its fund-raising plans through a Qualified Institutions Placement (QIP).

The company has informed the exchanges that total foreign investment in Swiggy stood at approximately 49.76 per cent of the total paid-up equity share capital as of July 6, 2026

HDFC Securities has recommended investors buy the stock in the ₹1,880-1,930 band and accumulate on dips in the ₹1,705-1,740 band (13x FY28E EPS)

Bank of Baroda shares have now fallen 23 per cent from their 52-week high of ₹325.50, touched on February 26, 2026, on the NSE

Despite Wednesday's gains, the stock continues to trade nearly 9 per cent below its IPO price, though it is about 8 per cent higher than its listing-day low on the NSE

The Navratna stock has gained nearly 32 per cent from its 52-week low touched earlier this year on March 30, 2026.

The rally followed the company's introduction of Tensai® for Reasoning Ops, described as the first generally available stage of its Tensai® Agentic ITOps platform.

Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals, has entered into a co-development and supply agreement with Orion Corporation

The northward movement in the share price came after the company said its management committee of the board approved the allotment of two series of NCDs aggregating ₹1,000 crore

HFCL shares have multiplied investor wealth over the past fourt months, surging about 250 per cent from their 52-week low of ₹59.82, touched earlier this year on January 27, 2026

Tata Communications informed exchanges that it has issued and allotted commercial paper aggregating to ₹400 crore

On the technical front, the stock has been under pressure after touching an all-time high of ₹3,115 in December 2024, entering a corrective phase thereafter

The company has received a Letter of Acceptance for the development of a Gems & Jewellery Park under the Public Private Partnership (PPP) mode at Raipur, Chhattisgarh